Clarithromycin sub-microemulsion injection and preparation method thereof

A technology for clarithromycin and injection, applied in the field of clarithromycin submicroemulsion injection and preparation thereof, can solve the problems of not mentioning sterilization, limiting sterilization methods and the like
CN101411686AInactive Publication Date: 2009-04-22ๅˆ˜็Ž‰่พ‰
1 Cites 9 Cited by

Patent Information

Authority / Receiving Office
CN ยท China
Patent Type
Applications(China)
Current Assignee / Owner
ๅˆ˜็Ž‰่พ‰
Publication Date
2009-04-22
Estimated Expiration
Not applicable ยท inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention belongs to the field of pharmaceutical preparation, and in particular relates to a clarithromycin submicron emulsion injection using phospholipid compound to carry medicine and a preparation method thereof. By 100 milliliters of the injection, the clarithromycin submicron emulsion injection comprises 0.05 to 0.5 gram of clarithromycin phospholipid compound in terms of clarithromycin, 10 to 20 grams of medium chain fatty acid triglyceride, 0 to 10 grams of soybean oil for injection, 0.2 to 2 grams of soya lecithin, 0.2 to 1 gram of Pluronic F-68, 0 to 0.5 gram of Tween-80, 0.01 to 0.05 gram of L-cysteine, 0.05 to 0.3 gram of sodium oleate, 2 to 5 grams of glycerin, and 70 to 90 grams of water for injection, wherein the mass ratio of clarithromycin in the clarithromycin phospholipid compound to the soya lecithin is between 1 to 1 and 1 to 12. The clarithromycin submicron emulsion injection has the advantages that the clarithromycin submicron emulsion injection has physical and chemical properties meeting requirement of medicine use for veins, not only can sterilize at high temperature, but also has favorable physical and chemical stability for long term storage, has little stimulation to the veins, improves adaptability of a patient, and is suitable for clinical application.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field

[0001] The invention belongs to the field of pharmaceutical preparations, and more specifically, relates to a clarithromycin submicroemulsion injection loaded with a phospholipid complex and a preparation method thereof. Background technique

[0002] Clarithromycin (clarithromycin) is a macrolide antibiotic developed by Taisho Pharmaceutical Company of Japan in 1981. Its chemical name is 6-O-methylerythromycin, and its chemical structure is as follows:

[0003]

[0004] Clarithromycin binds to the 50S subunit of the bacterial ribosome. By blocking the effect of transpeptidation and the process of mRNA translocation, it prevents the elongation of the peptide chain and inhibits the synthesis of bacterial protein, thereby producing antibacterial effects. Clarithromycin is mainly used in the treatment of local infections to treat respiratory tract infections, skin and soft tissue infections and urinary tract infections; in the treatment of digestive system diseases,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More